News ESSA Pharma Inc.

Equities

EPIX

CA29668H7085

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
6.24 ^USD	-0.16%		-9.30%	-5.45%

Mar. 06	Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
Mar. 06	Norway's wealth fund pushes for more women on emerging market company boards	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 09	PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	Mar. 07	PR
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	Mar. 07	AQ
Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call	Mar. 06
Norway's wealth fund pushes for more women on emerging market company boards	Mar. 06	RE
ESSA Pharma : Passive Foreign Investment Company Statement	Feb. 27	PU
ESSA Pharma: Fiscal Q1 Earnings Snapshot	Feb. 13	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	Feb. 13	AQ
ESSA Pharma Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 13	CI
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	PR
ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	Jan. 26	AQ
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	Jan. 25	PR
ESSA Pharma: Fiscal Q4 Earnings Snapshot	Dec. 12	AQ
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023	Dec. 12	AQ
ESSA Pharma Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	Dec. 12	CI
Essa Pharma Insider Bought Shares Worth $133,274, According to a Recent SEC Filing	Nov. 24	MT
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference	Nov. 21	PR
Essa Pharma Insider Bought Shares Worth $419,661, According to a Recent SEC Filing	Nov. 16	MT
ESSA Pharma to Present at the Jefferies London Healthcare Conference	Nov. 08	PR
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	Nov. 06	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ESSA Pharma Inc.

Equities

EPIX

CA29668H7085

Summary

Filters